Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates-Reference-Cited by-同舟云学术

Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates

Published:2019-11-08 Issue:1 Volume:125 Page:112-122
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Nguyen David‐Dan¹^ORCID,Barber Neil²,Bidair Mo³,Gilling Peter⁴^ORCID,Anderson Paul⁵,Zorn Kevin C.⁶,Badlani Gopal⁷,Humphreys Mitch⁸,Kaplan Steven⁹,Kaufman Ronald¹⁰,So Alan¹¹,Paterson Ryan¹¹,Goldenberg Larry¹¹,Elterman Dean¹²,Desai Mihir¹³,Lingeman Jim¹⁴,Roehrborn Claus¹⁵,Bhojani Naeem⁶^ORCID

Affiliation:

1. Faculty of Medicine McGill University Montreal QC Canada

2. Frimley Park Hospital, Urology Frimley Surrey UK

3. San Diego Clinical Trials San Diego CA USA

4. Bay of Plenty District Health Board Clinical School, Urology Tauranga New Zealand

5. Royal Melbourne Hospital, Urology Melbourne Victoria Australia

6. Centre Hospitalier de l’Université de Montréal Division of Urology Montreal QC Canada

7. Wake Forest School of Medicine, Urology Winston‐Salem NCUSA

8. Mayo Clinic, Department of Urology Phoenix AZUSA

9. Department of Urology Mount Sinai Hospital New York NYUSA

10. Division of Urology Albany Medical College Albany NY USA

11. University of British Columbia, Urologic Sciences Vancouver BC Canada